Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. BioNTech SE Sponsored ADR (BNTX) is a stock that can certainly grab the attention of ...

An expert panel of the EU drug regulator, the European Medicines Agency (EMA) on Friday recommended marketing authorizations ...

The race to develop effective cancer vaccines has entered a new phase, with late-stage trials from companies like Moderna ...

Investors in BioNTech SE (Symbol: BNTX) saw new options begin trading today, for the June 2026 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is ...

Investors in BioNTech SE (Symbol: BNTX) saw new options begin trading this week, for the April 1st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BNTX ...

On BioNTech's (BNTX) first-quarter 2024 earnings call, investors' focus is likely to be on the updates related to its pipeline development now that the pandemic is over.

Read about BioNTech SE ADR (BNTX:XNAS) stock and today's latest news and financial updates. BNTX - BioNTech SE ADR News | Morningstar Morningstar brands and products ...

BioNTech SE's turn toward oncology treatments has the potential to tap multi-billion-dollar markets in the future. Find out ...

BioNTech's (BNTX) fourth-quarter COVID-19 vaccine sales are likely to have declined with the pandemic largely in control. Updates on the company's booster dose authorization status and pipeline ...